Roche Holdings, a Swiss multinational healthcare company, completed the acquisition of Stratos Genomics, a DNA sequencing technology company. Financial terms were not disclosed. “Roche is dedicated to creating innovative diagnostics for the most challenging clinical conditions with techniques that are tailored to individual genetic and disease profiles. These solutions address the demands of research and clinical practice to deliver on the promise of personalised healthcare for patients. We look forward to further advancing our sequencing technology as we move to the next generation of healthcare and welcome the world-class scientists and employees from Stratos Genomics to Roche,” Thomas Schinecker, Roche CEO.